Article

Michael J. Mauro Discusses the Diagnosis of CML

Author(s):

Michael J. Mauro

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of melanoma
image of Kelsey Martin
Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.
Related Content
Linda Cohen is a survivor of small lymphocytic lymphoma and was diagnosed in 2009. Catch up on all of Linda's blogs here!
August 29th 2025

Standing Up to Cancer with Strength and a Positive Mindset

Linda Cohen
cancer horizons logo: a white microphone on a navy blue background
August 29th 2025

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about why she remains hopeful for the future or cancer vaccines.
August 29th 2025

Could Cancer Vaccines Become a Reality Within the Next Decade?

Kristen Dahlgren
Top Headlines on CAR-T Cell Therapy
August 29th 2025

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
Image of Linda Cohen.
August 29th 2025

Finding Freedom and Uncertainty in My Cancer Remission Pause

Linda Cohen
Mary Sansone is a two-time survivor of acute myeloid leukemia. Catch up on all of Mary's blogs here!
August 29th 2025

Celebrating Survival After Transplant: Appreciating My Donor

Mary Sansone